Conference Coverage TCT 2021 See All Content See past conferences November 04, 2021 November 06, 2021 News Conference News SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years (UPDATED) After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery. < > Myocarditis After COVID-19 Vaccine: Data ‘Reassure’ More and More Todd Neale November 04, 2021 OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III Shelley Wood November 04, 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021 News News Conference News TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021 News Conference News More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021 News Conference News PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021 News Conference News Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021 Slides Presentation PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021 Presentation CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure Presenter: Mohamed Abdel-Wahab November 05, 2021 Presentation FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG Presenter: William Fearon November 04, 2021 Presentation SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes Presenter: Rafael Romaguera November 04, 2021 @TCTMD Follow Us
News Conference News SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years (UPDATED) After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery.
OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III Shelley Wood November 04, 2021
FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Conference News TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Conference News More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021
News Conference News PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term Todd Neale November 05, 2021
News Conference News Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021
Presentation PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
Presentation CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure Presenter: Mohamed Abdel-Wahab November 05, 2021
Presentation FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG Presenter: William Fearon November 04, 2021
Presentation SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes Presenter: Rafael Romaguera November 04, 2021